Scolaris Content Display Scolaris Content Display

Effectiveness of the Valsalva Manoeuvre for reversion of supra‐ventricular tachycardia in the prehospital and emergency medicine settings

This is not the most recent version

Appendices

Appendix 1. Preliminary MEDLINE (OVID) search strategy for RCTs

1. Valsalva Maneuver/

2. valsalva*.tw.

3. exp Vagus Nerve/

4. vagal.tw.

5. Vagus Nerve Stimulation/

6. vagus.tw.

7. or/1‐6

8. exp Tachycardia, Supraventricular/

9. Tachycardia, Paroxysmal/

10. exp Tachycardia, Reciprocating/

11. (supraventric* adj4 arrhythmi*).tw.

12. (supra‐ventric* adj4 arrhythmi*).tw.

13. tachyarrhythmi*.tw.

14. svt.tw.

15. avrt.tw.

16. avnrt.tw.

17. tachycardi*.tw.

18. or/8‐17

19. 7 and 18

20. randomized controlled trial.pt.

21. controlled clinical trial.pt.

22. randomized.ab.

23. placebo.ab.

24. drug therapy.fs.

25. randomly.ab.

26. trial.ab.

27. groups.ab.

28. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27

29. exp animals/ not humans.sh.

30. 28 not 29

31. 19 and 30

Appendix 2. Preliminary MEDLINE (OVID) search strategy for adverse effects

 

1. Valsalva Maneuver/

2. valsalva*.tw.

3. exp Vagus Nerve/

4. vagal.tw.

5. Vagus Nerve Stimulation/

6. vagus.tw.

7. or/1‐6

8. exp Tachycardia, Supraventricular/

9. Tachycardia, Paroxysmal/

10. exp Tachycardia, Reciprocating/

11. (supraventric* adj4 arrhythmi*).tw.

12. (supra‐ventric* adj4 arrhythmi*).tw.

13. tachyarrhythmi*.tw.

14. svt.tw.

15. avrt.tw.

16. avnrt.tw.

17. tachycardi*.tw.

18. or/8‐17

19. 7 and 18

20. adverse effects.fs.

21. contraindications.fs.

22. poisoning.fs.

23. toxicity.fs.

24. drug effects.fs.

25. (toxi* adj2 (effect or effects or reaction* or event or events or outcome*)).tw.

26. (adverse* adj2 (effect or effects or reaction* or event or events or outcome*)).tw.

27. (side adj3 (effect or effects)).tw.

28. (adr or adrs).tw.

29. or/20‐28

30. exp animals/ not humans.sh.

31. 29 not 30

32. 19 and 31